BOUT
CapForce IBD Breakout Opportunities ETF
$44.13
$-0.03 (-0.08%)
Delayed ≥20 min · Sep 1, 2026
Key Statistics
Net Assets (AUM)
$15.45M
Expense Ratio
See prospectus
Previous Close
$44.13
Day Range
- – -
52-Week Range
$43.41 – $49.41
Volume
629
Avg Vol (50D)
3.69K
Beta
1.04
Historical Performance
1M
-4.55%
3M
-5.38%
6M
+6.55%
YTD
+21.57%
1Y
+17.19%
3Y
+40.94%
5Y
+28.77%
Total return including reinvested distributions, from adjusted closing prices.
Price History
Price history is being compiled for this fund.
Top Holdings
Detailed holdings are compiled from each fund’s latest SEC N-PORT portfolio filing.
About BOUT
ABOUT, INC.
BOUT News
- Discipline and Rules-Based Execution in BOUT Response
- Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) Sees Large Decline in Short Interest
- Short Interest in Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) Expands By 92.3%
- Responsive Playbooks and the BOUT Inflection
- Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) Short Interest Update
- Understanding the Setup: (BOUT) and Scalable Risk
- The Technical Signals Behind (BOUT) That Institutions Follow
- The Technical Signals Behind (BOUT) That Institutions Follow
- Precision Trading with Innovator Ibd(r) Breakout Opportunities Etf (BOUT) Risk Zones
- Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) Sees Large Decrease in Short Interest
Data for BOUT is aggregated from third-party providers (Tiingo, Nasdaq, Finnhub) and SEC filings, may be delayed at least 20 minutes, and may be incomplete or contain errors. Nothing here is investment advice. Verify with the official prospectus before investing.